journal article·2023-11

Biotin-modified cyclometalated iridium-based photosensitizers as mitochondria-targeted theranostic agents for tumor photodynamic therapy in vitro and in vivo

Lai Wei, Xiangdong He, Xinyue Shang, Martha Kandawa-Shultz, Guoqiang Shao, Yihong Wang

Dyes and Pigments· Volume 219
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Metal complexes synthesis and properties · Click Chemistry and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Cancer statistics, 2023
2. Mito-bomb: targeting mitochondria for cancer therapy
3. A light-induced nitric oxide controllable release nano-platform based on diketopyrrolopyrrole derivatives for pH-responsive photodynamic/photothermal synergistic cancer therapy10.1039/C8SC03386B ↗
4. Light-triggered clustered vesicles with self-supplied oxygen and tissue penetrability for photodynamic therapy against hypoxic tumor10.1002/adfm.201702108 ↗
5. Electrostatic self-assembled Iridium(III) nano-photosensitizer for selectively disintegrated and mitochondria targeted photodynamic therapy10.1016/j.dyepig.2019.108105 ↗
6. A tricarbonyl rhenium(I) complex decorated with boron dipyrromethene for endoplasmic reticulum-targeted photodynamic therapy10.1016/j.dyepig.2023.111077 ↗
7. AIE-active iridium(III) complex integrated with upconversion nanoparticles for NIR-irradiated photodynamic therapy10.1039/D2CC03622C ↗
8. NIR-II self-luminous molecular probe for in vivo inflammation tracking and cancer PDT effect self-evaluating10.1002/smll.202206666 ↗
9. Phototherapeutic anticancer strategies with first-row transition metal complexes: a critical review10.1039/D1CS00609F ↗
10. Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy10.1016/j.ccr.2018.01.010 ↗
11. Photoactivatable metabolic warheads enable precise and safe ablation of target cells in vivo10.1038/s41467-021-22578-2 ↗
12. Photosensitizers used in the photodynamic therapy of rheumatoid arthritis10.3390/ijms20133339 ↗
13. Multifunctional liposomes for image-guided intratumoral chemo-phototherapy10.1002/adhm.201700253 ↗
14. Nanoliposomes Co-encapsulating CT imaging contrast agent and photosensitizer for enhanced, imaging guided photodynamic therapy of cancer10.7150/thno.31079 ↗
15. Fine-tuning the electronic structure of heavy-atom-free BODIPY photosensitizers for fluorescence imaging and mitochondria-targeted photodynamic therapy10.1039/D0SC01171A ↗
16. A cyclometallated iridium(III) complex with multi-photon absorption properties as an imaging-guided photosensitizer10.1039/D2TB01023B ↗
17. The resurgence of platinum-based cancer chemotherapy10.1038/nrc2167 ↗
18. Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents10.1039/C5SC01955A ↗
19. Benzothiazole-decorated iridium-based nanophotosensitizers for photodynamic therapy of cancer cells10.1039/D1DT04315C ↗
20. Mitochondrial-DNA-targeted Ir(III) -containing metallohelices with tunable photodynamic therapy efficacy in cancer cells10.1002/anie.201915281 ↗
21. Photodecaging of a mitochondria-localized iridium(III) endoperoxide complex for two-photon photoactivated therapy under hypoxia10.1021/jacs.1c13137 ↗
22. Half-sandwich iridium and ruthenium complexes: effective tracking in cells and anticancer studies10.1021/acs.inorgchem.8b02161 ↗
23. Bichromophoric anticancer drug: targeting lysosome with rhodamine modified cyclometalated Iridium(III) complexes10.1016/j.dyepig.2018.10.019 ↗
24. Delivery of phosphorescent anticancer iridium(III) complexes by polydopamine nanoparticles for targeted combined photothermal-chemotherapy and thermal/photoacoustic/lifetime imaging10.1002/advs.201800581 ↗
25. Mechanistic dichotomy in the solvent dependent access to E vs. Z-allylic amines via decarboxylative vinylation of amino acids10.1039/D2SC02090D ↗
26. Blue phosphorescence and hyperluminescence generated from imidazo[4,5-b]pyridin-2-ylidene-based iridium(III) phosphors10.1002/advs.202201150 ↗
27. Heteroleptic Ir(III)N(6) complexes with long-lived triplet excited states and in vitro photobiological activities10.1021/acsami.8b14744 ↗
28. Ruthenium and iridium complexes bearing porphyrin moieties: PDT efficacy against resistant melanoma cells10.1016/j.dyepig.2022.110501 ↗
29. Mitochondria-targeted iridium-based photosensitizers enhancing photodynamic therapy effect by disturbing cellular redox balance10.1016/j.freeradbiomed.2022.12.091 ↗
30. Post-complexation functionalization of cyclometalated iridium(III) complexes and applications to biomedical and material sciences10.1007/s41061-022-00401-w ↗
31. Near infrared photoimmunotherapy for lung metastases10.1016/j.canlet.2015.05.018 ↗
32. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells10.2147/IJN.S182184 ↗
33. Probing biotin receptors in cancer cells with rationally designed fluorogenic squaraine dimers10.1039/D0SC01973A ↗
34. A new-type HOCl-activatable fluorescent probe and its applications in water environment and biosystems10.1016/j.scitotenv.2022.156164 ↗
35. Recent development of biotin conjugation in biological imaging, sensing, and target delivery10.1039/C5CC03075G ↗
36. Biotin conjugated organic molecules and proteins for cancer therapy: a review10.1016/j.ejmech.2018.01.001 ↗
37. A smart theranostic prodrug system activated by reactive oxygen species for regional chemotherapy of metastatic cancer10.1002/anie.202116807 ↗
38. Tumor cell-derived angiopoietin-2 promotes metastasis in melanoma10.1158/0008-5472.CAN-19-2660 ↗
39. Application of mitochondrially targeted nanoconstructs to neoadjuvant X-ray-induced photodynamic therapy for rectal cancer10.1021/acscentsci.9b01121 ↗
40. Combination of Ru(ii) complexes and light: new frontiers in cancer therapy10.1039/C4SC03759F ↗
41. A pH reversibly activatable NIR photothermal/photodynamic-in-one agent integrated with renewable nanoimplants for image-guided precision phototherapy10.1039/D0SC04408C ↗
42. Singlet oxygen treatment of tumor cells triggers extracellular singlet oxygen generation, catalase inactivation and reactivation of intercellular apoptosis-inducing signaling10.1016/j.redox.2015.07.006 ↗
43. Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA10.1038/nn.3787 ↗
44. A mitochondria-targeted nanoradiosensitizer activating reactive oxygen species burst for enhanced radiation therapy10.1039/C7SC04458E ↗
45. Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFkappaB activation and reduces its immunotoxicity10.1021/nn200283g ↗
46. Diatom-like silica-protein nanocomposites for sustained drug delivery of ruthenium polypyridyl complexes10.1016/j.jinorgbio.2021.111489 ↗
47. A fundamental role of the solvent polarity and remote substitution of the 2-(4-R-phenyl)-1H-imidazo[4,5-f][1,10]phenanthroline framework in controlling the ground- and excited-state properties of Re(I) chromophores [ReCl(CO)(3)(R-C(6)H(4)-imphen)]10.1039/D2DT02439J ↗
48. Turn-on phosphorescent chemodosimeter for Hg2+ based on a cyclometalated Ir(III) complex and its application in time-resolved luminescence assays and live cell imaging10.1021/ic501417s ↗
49. Influence of halogen atoms on a homologous series of bis-cyclometalated iridium(III) complexes10.1021/ic2011474 ↗
50. Unprecedented combination of regioselective hydrodefluorination and ligand exchange reaction during the syntheses of tris-cyclometalated iridium(III) complexes10.1039/c2dt32071a ↗